Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jole O. Rodriguez"'
Publikováno v:
Molecular pharmaceutics. 12(10)
In this work, we discuss leveraging the Biopharmaceutics Classification System (BCS) in the development of edivoxetine HCl, a selective norepinephrine reuptake inhibitor. First, the biopharmaceutical and in vivo data are presented and discussed. Solu
Publikováno v:
Drug Information Journal. 32:841-858
The advent of pre-New Drug Application (NDA) approval inspections in the early 1990s was not anticipated by the pharmaceutical industry. Thus, it is not surprising that the industry as a whole was not well prepared for these inspections. This is evid